Biogen (BIIB) option IV into Clinical Trials on Alzheimer's Congress

Go back to Biogen (BIIB) option IV into Clinical Trials on Alzheimer's Congress
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 200.59 +3.40 (1.72%)
Previous Close $197.19    52 Week High $333.65 
Open $199.34    52 Week Low $223.02 
Day High $202.00    P/E 25.68 
Day Low $198.83    EPS $7.81 
Volume 109,892